The global AI in oncology market is expected to experience substantial growth, driven by the increasing adoption of AI-powered solutions for cancer diagnosis, treatment planning, and patient care. This market is projected to reach US$ 7.7 billion by 2034, with a CAGR of 16.8%. AI is revolutionizing cancer care by enabling personalized treatment approaches, enhancing medical imaging interpretation, and accelerating drug discovery processes. North America currently leads the market, followed by Europe and Asia Pacific, each with their own unique strengths and growth drivers.
Results for: Cancer Care
In Alberta, cancer patients are experiencing significant delays in accessing specialist consultations. According to the Alberta Medical Association, patients are waiting three to four times longer than recommended standards to see an oncologist. This alarming trend has raised concerns among healthcare professionals, with some patients facing waits of up to 13 weeks for a radiation oncologist consultation. The prolonged wait times have dire consequences, potentially compromising patient outcomes and quality of life. The situation has prompted calls for increased recruitment and training of oncologists in the province.